Charles B. Nemeroff, MD, PhD

Negative Ethnic-Racial Identity and Internalizing Symptoms in Latiné Youth Exposed to Trauma

March 17, 2025

In a large group of Latiné youth who had experienced trauma, negative affect about their ethnic racial identity not only was associated with worse internalizing symptoms, but also increased...

Sunita M. Stewart, Nazan Aksan, Andrea Bancroft, et al

Original Research

Influence of Sex and Menopausal Status on Response, Remission, and Recurrence in Patients With Recurrent Major Depressive Disorder Treated With Venlafaxine Extended Release or Fluoxetine: Analysis of Data From the PREVENT Study

November 26, 2013

Susan G. Kornstein, Madhukar H. Trivedi, Michael E. Thase, et al

Commentary

The Pervasive and Persistent Neurobiological and Clinical Aftermath of Child Abuse and Neglect

October 15, 2013

Charles B. Nemeroff, Fred Seligman

Original Research

The Prevention of Recurrent Episodes of Depression With Venlafaxine for Two Years (PREVENT) Study: Outcomes From the 2-Year and Combined Maintenance Phases

August 15, 2007

David L. Dunner, Susan G. Kornstein, Alan F. Schatzberg, et al

Original Research

Prevention of Recurrent Episodes of Depression With Venlafaxine ER in a 1-Year Maintenance Phase From the PREVENT Study

July 16, 2007

David L. Dunner, Susan G. Kornstein, Alan F. Schatzberg, et al

Article

Prevalence and Management of Treatment-Resistant Depression

July 16, 2007

Charles B. Nemeroff

Article

A Double-Blind, Multicenter, Parallel-Group Study of Paroxetine, Desipramine, or Placebo in Breast Cancer Patients (stages I, II, III, and IV) With Major Depression

February 15, 2006

Charles B. Nemeroff, Dwight L. Evans, Dominique L. Musselman, et al

Article

Use of Atypical Antipsychotics in Refractory Depression and Anxiety

November 15, 2005

Charles B. Nemeroff

Article

Introduction.

November 15, 2005

Charles B. Nemeroff

Original Research

Aripiprazole Augmentation of Antidepressants for the Treatment of Partially Responding and Nonresponding Patients With Major Depressive Disorder

October 14, 2005

Charles B. Nemeroff, Jeffrey S. Simon

Article

The Neurobiology of Depression: Inroads to Treatment and New Drug Discovery

August 15, 2005

Charles B. Nemeroff, Wylie W. Vale

Article

Introduction. Developmental Neurobiology and Psychiatry: Challenges and Best Practices for Studies in Children and Adolescents

August 15, 2005

Karen Dineen Wagner, Charles B. Nemeroff

Negative Ethnic-Racial Identity and Internalizing Symptoms in Latiné Youth Exposed to Trauma

Influence of Sex and Menopausal Status on Response, Remission, and Recurrence in Patients With Recurrent Major Depressive Disorder Treated With Venlafaxine Extended Release or Fluoxetine: Analysis of Data From the PREVENT Study

The Pervasive and Persistent Neurobiological and Clinical Aftermath of Child Abuse and Neglect

The Prevention of Recurrent Episodes of Depression With Venlafaxine for Two Years (PREVENT) Study: Outcomes From the 2-Year and Combined Maintenance Phases

Prevention of Recurrent Episodes of Depression With Venlafaxine ER in a 1-Year Maintenance Phase From the PREVENT Study

Prevalence and Management of Treatment-Resistant Depression

A Double-Blind, Multicenter, Parallel-Group Study of Paroxetine, Desipramine, or Placebo in Breast Cancer Patients (stages I, II, III, and IV) With Major Depression

Use of Atypical Antipsychotics in Refractory Depression and Anxiety

Introduction.

Aripiprazole Augmentation of Antidepressants for the Treatment of Partially Responding and Nonresponding Patients With Major Depressive Disorder

The Neurobiology of Depression: Inroads to Treatment and New Drug Discovery

Introduction. Developmental Neurobiology and Psychiatry: Challenges and Best Practices for Studies in Children and Adolescents

ELSEWHERE:

FOLLOW US:

Charles B. Nemeroff, MD, PhD

Negative Ethnic-Racial Identity and Internalizing Symptoms in Latiné Youth Exposed to Trauma

Influence of Sex and Menopausal Status on Response, Remission, and Recurrence in Patients With Recurrent Major Depressive Disorder Treated With Venlafaxine Extended Release or Fluoxetine: Analysis of Data From the PREVENT Study

The Pervasive and Persistent Neurobiological and Clinical Aftermath of Child Abuse and Neglect

The Prevention of Recurrent Episodes of Depression With Venlafaxine for Two Years (PREVENT) Study: Outcomes From the 2-Year and Combined Maintenance Phases

Prevention of Recurrent Episodes of Depression With Venlafaxine ER in a 1-Year Maintenance Phase From the PREVENT Study

Prevalence and Management of Treatment-Resistant Depression

A Double-Blind, Multicenter, Parallel-Group Study of Paroxetine, Desipramine, or Placebo in Breast Cancer Patients (stages I, II, III, and IV) With Major Depression

Use of Atypical Antipsychotics in Refractory Depression and Anxiety

Introduction.

Aripiprazole Augmentation of Antidepressants for the Treatment of Partially Responding and Nonresponding Patients With Major Depressive Disorder

The Neurobiology of Depression: Inroads to Treatment and New Drug Discovery

Introduction. Developmental Neurobiology and Psychiatry: Challenges and Best Practices for Studies in Children and Adolescents

Insightful. Evidence-based. Human-centered.

Subscribe to readmore articles

Subscribe to read
more articles